RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights

By / 17/08/2023

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today provided first half, 2023, financial results and operational highlights.